A low globulin level on a blood test usually signals that your body is not producing enough immune proteins, is losing them faster than it can replace them, or both. Globulins are a broad family of proteins in your blood, and the most clinically significant fraction is immunoglobulins, the antibodies your immune system uses to fight infections. When the globulin number drops, the most common real-world consequence is increased vulnerability to bacterial and viral infections, though the underlying reason for the drop can range from a medication side effect to an inherited immune disorder to a blood cancer. The finding itself is not a diagnosis but a red flag that prompts further investigation.
What “Globulin” Actually Measures
On a standard metabolic panel, the globulin number is usually not measured directly. Instead, it is calculated by subtracting albumin (the most abundant blood protein) from total protein. What remains is called “calculated globulin,” and it lumps together several distinct protein groups: alpha-1 globulins, alpha-2 globulins, beta globulins, and gamma globulins. The gamma fraction is overwhelmingly made up of immunoglobulins (IgG, IgA, IgM, and others), and a drop in this fraction is what most clinicians worry about when they see a low calculated globulin value.
Because calculated globulin is an indirect measure, the number can be thrown off by anything that changes albumin or total protein independently. Overhydration from intravenous fluids, for instance, dilutes all blood proteins and can make globulin look artificially low. Liver disease that reduces albumin production can paradoxically make the globulin fraction appear normal or high even when immunoglobulins are actually falling. This is why a low calculated globulin is best treated as a screening signal rather than a final answer. One study found that using a calculated globulin cutoff captured the vast majority of patients who turned out to have genuinely low IgG levels, with about 86% of samples flagged at that threshold confirmed to have IgG below 6 g/L on direct measurement.1PubMed Central. A Single Center Study Investigating Clinical Outcomes of Testing for Multiple Myeloma and Immune Deficiency at Low Globulin Levels
The Most Common Causes
Doctors broadly divide the causes of low globulin into primary (you were born with a problem in immune protein production) and secondary (something acquired along the way is suppressing or depleting your globulin). Secondary causes are far more common in adults, and medications are among the most frequent culprits.
Medications and Medical Treatments
Corticosteroids, the anti-inflammatory drugs used for conditions like asthma, lupus, and organ transplants, can suppress immunoglobulin production and increase the rate at which existing antibodies are broken down. Research has shown that the daily dose of corticosteroids matters more than how long you take them, and low IgG levels can persist even after you stop the medication.2PubMed Central. Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism Other immune-suppressing drugs, including those used for rheumatologic diseases and certain antiseizure medications, can also drive globulin levels down.3Immunology and Allergy Clinics of North America. Secondary Hypogammaglobulinemia
Rituximab, a biologic drug widely used for lymphoma, rheumatoid arthritis, and certain autoimmune conditions, deserves special mention. It works by depleting B cells, the immune cells responsible for making antibodies. The immunoglobulin drop can last months to years after the final infusion, and some patients need ongoing antibody replacement therapy. In one study of patients who had finished rituximab treatment, immunoglobulin replacement raised IgG levels significantly above what they had been at the end of treatment.4PubMed. Intravenous versus subcutaneous immunoglobulin replacement in secondary hypogammaglobulinemia
Blood Cancers
Chronic lymphocytic leukemia (CLL) is one of the most common blood cancers in older adults, and low globulin is a frequent companion. About a quarter of newly diagnosed CLL patients already have low IgG levels at the time of diagnosis. Among those who start with normal IgG, about one in ten develops low levels within five years even without treatment, and roughly one in four does so within a decade.5PubMed Central. Hypogammaglobulinemia in Newly Diagnosed Chronic Lymphocytic Leukemia: Natural History, Clinical Correlates and Outcomes The cancer itself crowds out healthy immune cells and disrupts normal antibody production. Other blood cancers, including multiple myeloma and non-Hodgkin lymphoma, can have similar effects. In fact, screening for low calculated globulin has been used as a way to catch previously undiagnosed myeloma: one center’s screening program detected new cases of light-chain and non-secretory myeloma in roughly 2% of patients flagged for low globulin.1PubMed Central. A Single Center Study Investigating Clinical Outcomes of Testing for Multiple Myeloma and Immune Deficiency at Low Globulin Levels
Protein Loss Through Skin, Gut, or Kidneys
Your body can also lose globulins faster than it makes them. Major burn injuries covering more than about 15% of the body surface cause capillary leak, a state where the smallest blood vessels become abnormally permeable and proteins, including immunoglobulins, pour out into damaged tissue. This protein loss contributes to the heightened infection risk that burn patients face.6Burns. A qualitative and quantitative analysis of protein loss in human burn wounds Protein-losing enteropathy, a group of gut conditions where protein leaks into the intestinal tract, and nephrotic syndrome, where the kidneys’ filters become too leaky and dump protein into the urine, are other well-established routes for globulin depletion.
Inherited Immune Deficiencies
Some people are born with genetic mutations that prevent normal antibody production. These primary immunodeficiencies are rarer than the acquired causes but tend to be more severe and lifelong. The two most common forms in adults are common variable immunodeficiency (CVID) and selective IgA deficiency. CVID involves a broad failure to make adequate amounts of multiple immunoglobulin types, while selective IgA deficiency affects just one class and is often mild enough that people live for years without knowing they have it.
In children, X-linked agammaglobulinemia is an important diagnosis. It almost exclusively affects boys because the responsible gene sits on the X chromosome, and it results in near-total absence of antibody production. Severe combined immunodeficiency (SCID), sometimes called “bubble boy disease” in popular culture, is the most extreme form, affecting both antibody-producing cells and other immune cells. Newborn screening programs now test for SCID in many countries because early treatment, including bone marrow transplant, can be lifesaving.
What Low Globulin Feels Like
A mildly low globulin level often produces no symptoms at all, and many people discover it incidentally on routine bloodwork. As levels drop further, the hallmark problem is recurrent infections, especially bacterial infections of the sinuses, lungs, and ears. Pneumonia that keeps coming back, sinus infections that never fully clear, or ear infections in adults (which are uncommon in immunocompetent people) are all patterns that should raise suspicion.
The infections tend to involve “encapsulated” bacteria, the type surrounded by a protective coating that antibodies are particularly good at targeting. Without enough antibodies, your immune system struggles to tag these bacteria for destruction. Some patients also develop chronic diarrhea from recurrent gastrointestinal infections, and over time, repeated lung infections can cause permanent airway damage called bronchiectasis. This is why identifying and treating low globulin matters even when the drop seems modest: the cumulative damage from years of poorly controlled infections can be significant.
How Doctors Investigate Further
When a calculated globulin value comes back low, the next step is usually a serum protein electrophoresis (SPEP) and direct measurement of immunoglobulin levels (IgG, IgA, and IgM individually). The electrophoresis separates blood proteins by electrical charge, producing a characteristic pattern that can reveal whether the gamma fraction is genuinely reduced and whether any abnormal protein bands (paraproteins) are present. One screening study found that reflex testing triggered by low calculated globulin values uncovered previously undetected small paraproteins associated with immune suppression in about 1.2% of samples.7PubMed Central. Calculated globulin (CG) as a screening test for antibody deficiency
If immunoglobulin levels are confirmed to be low, doctors look for the cause. This involves checking medication history, screening for blood cancers with a complete blood count and flow cytometry, evaluating kidney and liver function, and sometimes checking for protein loss through the gut or urine. In younger patients or those without an obvious secondary cause, genetic testing for primary immunodeficiency may be appropriate. The diagnostic workup matters because treatment depends entirely on why the globulin is low. Stopping a medication is very different from starting lifelong antibody replacement.
Treatment Depends on the Cause
If a medication is responsible, the simplest fix is to stop or switch the drug, though this is not always possible when the medication treats a serious condition. For patients whose low globulin stems from an untreatable cause, such as a primary immunodeficiency or a blood cancer that cannot be cured, immunoglobulin replacement therapy is the standard approach. This involves infusing pooled human antibodies collected from thousands of blood donors.
Replacement therapy comes in two forms: intravenous (IVIG), given in a clinic every few weeks, and subcutaneous (SCIG), which patients can self-administer at home more frequently in smaller doses. Both effectively raise IgG levels to a protective range, and both mechanical and electronic infusion systems used for subcutaneous delivery achieve therapeutic targets consistently.8PubMed Central. Mechanical versus Electronic Infusion Systems in Subcutaneous Immunoglobulin Therapy: A Structured Literature Review of Infusion-Site Reactions and Device Performance Evidence suggests that subcutaneous delivery may produce slightly higher and more stable IgG levels compared to intravenous infusions, likely because the frequent small doses avoid the peak-and-trough pattern that comes with monthly infusions.4PubMed. Intravenous versus subcutaneous immunoglobulin replacement in secondary hypogammaglobulinemia Many patients prefer the subcutaneous route because it avoids regular clinic visits, though some find the home infusion process burdensome in its own way.
Beyond replacement therapy, patients with chronically low globulin are often counseled on infection prevention: prompt antibiotic treatment for bacterial infections, annual flu vaccination (though the response may be blunted), and in some cases prophylactic antibiotics to prevent recurrent infections in the first place.
Low Globulin in Babies and Young Children
All healthy newborns go through a period of naturally low immunoglobulin production. During pregnancy, the mother’s IgG crosses the placenta, giving the baby passive protection for the first few months of life. After birth, those maternal antibodies gradually break down, and the baby’s own immune system takes over production. There is a normal dip in IgG levels around three to six months of age before the baby’s production catches up.
In some infants, this catch-up is delayed. The condition, called transient hypogammaglobulinemia of infancy, involves a prolonged period of low IgG beyond the expected timeframe. One study found that affected infants had abnormally delayed onset of their own IgG production and lacked specific antiviral antibodies that healthy infants of the same age had already developed.9PubMed. Absent specific viral antibodies in patients with transient hypogammaglobulinemia of infancy The good news is that these children typically outgrow the problem, with immunoglobulin levels normalizing by age two to four. The challenge for pediatricians is distinguishing transient hypogammaglobulinemia from a true primary immunodeficiency, which will not resolve on its own. Serial blood tests over time are usually the answer: if levels are steadily rising, watchful waiting is reasonable; if they plateau at abnormally low levels, further genetic workup is warranted.
Alpha-1-Antitrypsin Deficiency Is a Different Animal
Not all low globulin findings point to an antibody problem. Alpha-1-antitrypsin (AAT) is a protein that falls in the alpha-1 globulin fraction, and its deficiency is a hereditary condition that can subtly lower the total globulin number without affecting immunoglobulin levels at all.10PubMed Central. Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis AAT’s main job is to protect lung tissue from damage by enzymes released during inflammation. When AAT is deficient, those enzymes chew up lung tissue unchecked, leading to early-onset emphysema, often in people who have never smoked or who develop severe lung disease with only light smoking histories.
AAT deficiency also affects the liver, because the abnormal protein can accumulate in liver cells rather than being secreted into the blood. This can cause liver scarring and, in some cases, liver failure. The condition is substantially underdiagnosed. Many people with AAT deficiency go years with unexplained lung disease before the connection is made. If your low globulin is accompanied by lung or liver symptoms and your immunoglobulin levels are normal, AAT deficiency is worth asking your doctor about. A simple blood test can measure AAT levels directly, and genetic testing can confirm the specific mutation.
When a Low Globulin Level Can Be Ignored
Context matters enormously. A marginally low calculated globulin on a single blood draw, in a person who feels healthy and has no unusual infection history, is often meaningless. The calculation depends on accurate albumin measurement, and albumin itself fluctuates with hydration, nutrition, and even the specific laboratory technique used to measure it. One study examining calculated globulin as a screening tool noted meaningful differences in detection rates depending on whether the lab used bromocresol green or bromocresol purple to measure albumin, with the green method flagging patients at a threshold of 18 g/L and the purple method requiring a threshold of 23 g/L to capture the same proportion of truly low-IgG samples.7PubMed Central. Calculated globulin (CG) as a screening test for antibody deficiency
Acute illness, recent surgery, or heavy intravenous fluid administration can all temporarily dilute blood proteins. A single low reading in the hospital, especially after major fluid resuscitation, is rarely a true reflection of your baseline immune status. If you are otherwise well, your doctor may simply recheck the level in a few weeks. A persistently low value, or a low value paired with recurrent infections, warrants the deeper workup described earlier.
Secondary Antibody Deficiency Is Increasingly Common
As more people take immune-modifying drugs for autoimmune diseases, cancer, and organ transplants, secondary antibody deficiency is becoming a bigger part of clinical practice. In one cohort of patients flagged for low globulin, roughly half had secondary antibody deficiency caused by a blood cancer, and another 20% had immune deficiency caused by immunosuppressive medications or antiepileptic drugs.1PubMed Central. A Single Center Study Investigating Clinical Outcomes of Testing for Multiple Myeloma and Immune Deficiency at Low Globulin Levels The corticosteroid connection is particularly relevant because these drugs are prescribed so widely: from short courses for poison ivy to years-long regimens for organ transplant recipients. Low IgG related to corticosteroids appears to be driven more by the size of each daily dose than by the cumulative duration of treatment, and the immunoglobulin drop can outlast the prescription itself.2PubMed Central. Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism
Cushing syndrome, a condition where the body produces too much cortisol on its own (from an adrenal or pituitary tumor), can cause the same immunoglobulin drop without any external medication being involved. This is an underappreciated cause of secondary antibody deficiency and can be missed when clinicians focus only on drug-induced explanations.
How Passive Immune Transfer Works in Newborn Animals
The biology behind low globulin in newborns extends beyond human medicine and offers an illuminating parallel. In many species, including cattle, antibodies do not cross the placenta the way they do in humans. Calves are born with essentially zero circulating immunoglobulins and depend entirely on colostrum, the antibody-rich first milk, absorbed through the gut in the first hours of life. Failure of this passive transfer is a major cause of illness and death in beef calves, with studies estimating the prevalence of failed transfer at anywhere from about 6% to 35% depending on the herd and the threshold used.11PubMed Central. Failure of Passive Immune Transfer in Neonatal Beef Calves: A Scoping Review The window for gut absorption of intact immunoglobulins closes within about 24 hours after birth, making timely colostrum intake critical.
This veterinary parallel underscores a fundamental point about globulin biology: these proteins do not just appear in the blood because the body decides to make them. They require functioning immune cells, adequate nutrition, and in neonates, a reliable transfer mechanism. Whether the problem is a genetic defect in B cells, a drug that suppresses them, a cancer that crowds them out, or a newborn calf that did not nurse soon enough, the downstream consequence is the same: too few antibodies and too little protection against infection.